ArticleScientific reports2018

miR-429 suppresses tumor migration and invasion by targeting CRKL in hepatocellular carcinoma via inhibiting Raf/MEK/ERK pathway and epithelial-mesenchymal transition.

Chunmei Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.